HOME
PRODUCTS
COMPANY
CONTACT
FAQ
Research
Dictionary
Pharma
Sign Up
FREE
or
Login
Username:
Password:
Remember login
Login
Send password reminder...
Ingele Casteels Selected Research
Ingele Casteels Research Topics
Disease
3
Uveitis
09/2021 - 10/2014
3
Cystinosis
12/2019 - 06/2016
3
Retinopathy of Prematurity (Retrolental Fibroplasia)
06/2012 - 03/2003
2
Hemorrhage
01/2024 - 05/2021
2
Glaucoma
02/2022 - 01/2009
2
Neurofibromatosis 1 (Neurofibromatosis Type I)
01/2017 - 01/2002
1
Nephritis
01/2024
1
Arthritis (Polyarthritis)
01/2024
1
Esotropia (Esophoria)
01/2022
1
Myopia
01/2022
1
Hyperopia (Hypermetropia)
01/2022
1
Intermediate Uveitis (Chronic Cyclitis)
09/2021
1
Phlebitis
09/2021
1
Multiple Sclerosis
09/2021
1
Blue rubber bleb nevus syndrome
05/2021
1
Bruton type agammaglobulinemia
01/2021
1
Infections
01/2021
1
Choroidal Effusions
10/2020
1
Cysts
01/2020
1
Sepsis (Septicemia)
01/2020
1
Disease Progression
01/2019
1
Arteriovenous Malformations (Arteriovenous Malformation)
09/2018
1
Multifocal Choroiditis
01/2018
1
Roifman syndrome
01/2018
1
Panuveitis
01/2018
1
Inborn Genetic Diseases (Disease, Hereditary)
01/2018
1
Photophobia (Light Sensitivity)
06/2017
1
Eye Diseases (Eye Disease)
06/2017
1
Retinitis Pigmentosa (Pigmentary Retinopathy)
01/2017
1
Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
01/2016
1
Hepatitis C
01/2016
1
Optic Nerve Diseases (Optic Neuropathy)
01/2016
1
Pain (Aches)
06/2015
1
Blindness (Hysterical Blindness)
05/2015
1
Early Onset Severe Retinal Dystrophy
01/2015
1
Retinal Dystrophies
09/2014
1
Cataract (Cataracts)
02/2014
1
Weight Gain
09/2013
1
Vascular Diseases (Vascular Disease)
06/2012
1
Birth Weight (Birth Weights)
05/2012
1
Vision Disorders (Hemeralopia)
02/2012
1
congenital stationary Night blindness
02/2012
1
Edema (Dropsy)
11/2009
1
Macular Edema
11/2009
1
Port-Wine Stain (Nevus Flammeus)
01/2005
1
Ventricular Heart Septal Defects (Ventricular Septal Defect)
01/2005
1
Pulmonary Atresia (Pulmonary Valve Atresia)
01/2005
1
Glioma (Gliomas)
01/2002
Drug/Important Bio-Agent (IBA)
9
Retinaldehyde (Retinal)
IBA
09/2021 - 01/2005
3
Cystine (L-Cystine)
IBA
12/2019 - 06/2016
3
Cysteamine (Mercaptamine)
FDA Link
12/2019 - 06/2016
2
Fluorescein (Funduscein)
FDA Link
Generic
09/2021 - 11/2009
2
Oxygen (Dioxygen)
IBA
01/2020 - 09/2013
2
Carboplatin (JM8)
FDA Link
Generic
01/2019 - 01/2002
2
Steroids
IBA
10/2014 - 11/2009
1
Coatomer Protein (Archain)
IBA
01/2024
1
Mydriatics (Cycloplegics)
IBA
01/2022
1
Tablets
IBA
01/2022
1
HLA-DRB1 Chains (HLA DRB1)
IBA
09/2021
1
Adrenal Cortex Hormones (Corticosteroids)
IBA
09/2021
1
Propranolol (Inderal)
FDA Link
Generic
05/2021
1
Acetazolamide (Diamox)
FDA Link
Generic
10/2020
1
Ophthalmic Solutions (Eye Drops)
IBA
12/2019
1
Paclitaxel (Taxol)
FDA Link
Generic
01/2019
1
RNA (Ribonucleic Acid)
IBA
01/2018
1
Small Nuclear RNA (snRNA)
IBA
01/2018
1
Tubulin
IBA
01/2018
1
RNA Splicing Factors
IBA
01/2017
1
Calcineurin Inhibitors
IBA
01/2016
1
Antiviral Agents (Antivirals)
IBA
01/2016
1
ametantrone (HAQ)
IBA
06/2015
1
c-Mer Tyrosine Kinase
IBA
09/2014
1
Transcription Factors (Transcription Factor)
IBA
02/2014
1
Indicators and Reagents (Reagents)
IBA
09/2013
1
Glucose (Dextrose)
FDA Link
Generic
05/2012
1
Latanoprost (Xalatan)
FDA Link
01/2009
1
Betaxolol (Kerlon)
FDA Link
Generic
01/2009
1
Brimonidine Tartrate (Alphagan)
FDA Link
Generic
01/2009
1
Timolol (Blocadren)
FDA Link
Generic
01/2009
1
Carbonic Anhydrase Inhibitors
IBA
01/2009
1
dorzolamide (Trusopt)
FDA Link
Generic
01/2009
1
Synthetic Prostaglandins (Prostaglandin Analogues)
IBA
01/2009
1
Vincristine (Oncovin)
FDA Link
Generic
01/2002
Therapy/Procedure
4
Therapeutics
01/2018 - 01/2009
2
Vitrectomy
10/2020 - 01/2020
1
Trabeculectomy (Trabeculoplasty)
02/2022
1
Orthoptics (Orthoptic)
01/2022
1
Hematopoietic Stem Cell Transplantation
01/2021
1
Blood Transfusion (Blood Transfusions)
01/2020
1
Radiotherapy
01/2019
1
Immunomodulation
01/2018
1
Transplantation
06/2016
1
Liver Transplantation
01/2016
1
Cryotherapy (Therapy, Cold)
03/2003
1
Drug Therapy (Chemotherapy)
01/2002
1
Aftercare (After-Treatment)
01/2002